Related Experiment Video
Updated: Aug 29, 2026

A Novel Stromal Fibroblast-Modulated 3D Tumor Spheroid Model for Studying Tumor-Stroma Interaction and Drug Discovery
Published on: February 28, 2020
Fibroblast growth factor 2 induces differentiation and apoptosis of Askin tumour cells
Min-Suk Kim1, Chong Jai Kim, Hyun Sook Jung
1Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
Abstract:
Peripheral primitive neuroectodermal tumour (PNET)/Ewing's sarcoma (ES) and neuroblastoma (NB) are related tumours of neural crest origin with primitive neural characteristics. Fibroblast growth factor 2 (FGF2) is a critical signalling molecule for primitive neural crest cells. The treatment of NB cells with FGF2 variably affects biological characteristics such as growth and differentiation, while in PNET/ES, FGF2 predominantly induces apoptosis. The JK-GMS Askin tumour cell line can be induced to differentiate upon treatment with nerve growth factor (NGF), indicating the integrity of the cellular machinery necessary for differentiation. The present study assesses whether FGF2 can induce differentiation in JK-GMS cells. JK-GMS cells expressed high-affinity FGF receptors (FGFRs), and treatment with FGF2 induced phosphorylation of FGFR1 together with activation of extracellular signal-regulated kinases (ERK1/ERK2) and c-Jun N-terminal kinase (JNK). Subsequent biological effects were growth inhibition, neuronal differentiation, and apoptosis, and these changes were associated with increased expression of neurofilaments, reduction of c-myc and bcl-2 expression, and activation of caspase 3. Treatment of the cells with a specific inhibitor of the MAPK/extracellular signal-regulated kinase (MEK)-1, PD98059, predominantly inhibited the effects of FGF2 on growth, differentiation, and apoptosis, while an inhibitor of JNK reduced apoptosis, indicating that the ERK1/2 and JNK pathways are critical components of FGF2-mediated effects in JK-GMS cells. Additional comparative analyses of FGF2-mediated effects in two ES cell lines (CADO-ES, RD-ES) and a PNET cell line (SK-N-MC) showed pronounced differentiation in SK-N-MC, but not in CADO-ES or RD-ES cells. This study demonstrates that FGF2 can induce neuronal differentiation of PNET including Askin tumour. These findings clearly indicate that the FGF2-mediated signalling pathway plays a critical role in controlling the major properties of PNET cells and may provide a potential therapeutic target for PNET.
Insights
Fibroblast growth factor 2 (FGF2) induces neuronal differentiation and apoptosis in peripheral primitive neuroectodermal tumour (PNET) cells, including Askin tumour. This highlights FGF2 signaling as a potential therapeutic target for PNET.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- Peripheral primitive neuroectodermal tumour (PNET)/Ewing's sarcoma (ES) and neuroblastoma (NB) are neural crest-derived tumors.
- Fibroblast growth factor 2 (FGF2) influences neural crest cell biology, inducing apoptosis in PNET/ES and variable effects in NB.
- The JK-GMS Askin tumor cell line differentiates with nerve growth factor (NGF), confirming differentiation machinery integrity.
Purpose of the Study:
- To investigate whether FGF2 can induce differentiation in JK-GMS PNET cells.
- To elucidate the signaling pathways involved in FGF2-mediated effects in PNET cells.
- To compare FGF2 effects across different PNET and ES cell lines.
Main Methods:
- Treatment of JK-GMS cells with FGF2 and pathway inhibitors (PD98059 for MEK1, JNK inhibitor).
- Assessment of FGFR phosphorylation, ERK1/2 and JNK activation.
- Analysis of biological effects including growth, differentiation, apoptosis, and gene expression (neurofilaments, c-myc, bcl-2, caspase 3).
Main Results:
- FGF2 treatment activated FGFR1, ERK1/2, and JNK pathways in JK-GMS cells.
- FGF2 induced growth inhibition, neuronal differentiation, apoptosis, increased neurofilaments, and altered c-myc/bcl-2 expression.
- FGF2 promoted significant neuronal differentiation in the SK-N-MC PNET cell line, but not in CADO-ES or RD-ES Ewing's sarcoma cell lines.
Conclusions:
- FGF2 effectively induces neuronal differentiation and apoptosis in PNET, including Askin tumor cells.
- The ERK1/2 and JNK signaling pathways are critical mediators of FGF2's effects in PNET cells.
- The FGF2 signaling pathway represents a promising therapeutic target for PNET.
Related Concept Videos
Introduction to Fibroblasts
The Intrinsic Apoptotic Pathway
TGF - β Signaling Pathway
The Extrinsic Apoptotic Pathway
